Arrowhead Research Corporation Stock Forecast NASDAQ:ARWR

Price Target and Analyst Ratings

Most Recent Rating

On August 10, 2021 "HC Wainwright" gave "$95.00 - $100.00" rating for ARWR. The price target was changed from $62.78 to 3.1%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-08-10	$95.00 - $100.00	Target Raised by	HC Wainwright	$61.21	$62.78→3.1%
2021-08-06	$94.00 - $97.00	Target Raised by	Chardan Capital	$64.79	$68.05+2.9%
2021-08-06	$97.00 - $94.00	Target Lowered by	Chardan Capital	$64.79	$68.05+2.9%
2021-07-02	Buy	Reiterated by	HC Wainwright	$63.13	$95.00
2021-07-02	Buy	Reiterated by	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	$63.13	$95.00
2021-07-02	Overweight	Target Lowered by	Piper Sandler	$63.13	$109.00 → $89.00
2021-06-27	Hold	Reiterated by	SVB Leerink	$90.32
2021-06-21	Overweight - Overweight	Target Raised by	Piper Sandler	$89.81	$99.00 → $109.00
2021-02-08	Buy	Target Raised by	B. Riley	$88.41	$98.00 → $106.00
2021-02-08		Target Raised by	Citigroup	$88.41	$90.00 → $110.00
2021-02-08	Buy	Reiterated by	B. Riley	$88.41	$98.00 → $106.00
2021-02-05	Overweight	Target Raised by	Piper Sandler	$90.47	$90.00 → $99.00
2021-02-05	Buy	Target Raised by	HC Wainwright	$90.47	$90.00 → $95.00
2021-02-05	Buy	Target Raised by	Chardan Capital	$90.47	$81.00 → $97.00
2021-02-05	Buy	Reiterated by	HC Wainwright	$90.47	$90.00 → $95.00
2020-12-21	Outperform - Neutral	Downgraded by	Robert W. Baird	$82.03	$75.00
2020-12-15	Buy	Initiated by	UBS Group	$76.45
2020-11-24	Positive - Outperform	Target Raised by	Royal Bank of Canada	$60.39	$62.00 → $80.00
2020-11-24	Overweight	Target Raised by	Cantor Fitzgerald	$60.39	$58.00 → $80.00
2020-11-24	Market Perform	Target Lowered by	SVB Leerink	$60.39	$35.00 → $34.00
2020-11-19	Buy	Initiated by	Smith Barney Citigroup	$68.92	$90.00
2020-11-19	Buy	Initiated by	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	$68.92	$90.00
2020-11-17	Buy - Positive	Target Raised by	B. Riley	$70.79	$68.00 → $98.00
2020-11-16	Outperform	Target Raised by	Robert W. Baird	$69.07	$70.00 → $75.00
2020-10-12		Target Raised by	B. Riley	$46.39	$57.00 → $68.00
2020-10-12	Buy	Reiterated by	HC Wainwright	$46.39
2020-10-08		Target Raised by	Piper Sandler	$48.01	$80.00 → $90.00
2020-09-17	Market Perform	Target Raised by	SVB Leerink	$45.75	$29.00 → $31.00
2020-07-29	Buy	Reiterated by	Chardan Capital	$44.30	$81.00
2020-05-12	Outperform	Initiated by	Royal Bank of Canada	$35.94
2020-05-08	Market Perform - Outperform	Upgraded by	Oppenheimer	$34.14	$58.00
2020-05-08	Buy	Reiterated by	Cantor Fitzgerald	$34.14	$60.00 → $58.00
2020-04-15	Neutral - Overweight	Upgraded by	Cantor Fitzgerald	$35.33	$55.00 → $60.00

ARWR Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -18.60% during the next 3 months and, with a 90% probability hold a price between $42.91 and $60.56 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-22	$52.44	$63.28	$74.13
2021-09-23	$52.17	$63.01	$73.86
2021-09-24	$51.90	$62.74	$73.59
2021-09-27	$51.63	$62.47	$73.32
2021-09-28	$51.36	$62.20	$73.05
2021-09-29	$51.09	$61.93	$72.78
2021-09-30	$50.82	$61.66	$72.51
2021-10-01	$50.55	$61.39	$72.24
2021-10-04	$50.28	$61.12	$71.97
2021-10-05	$50.01	$60.85	$71.70
2021-10-06	$49.74	$60.58	$71.43
2021-10-07	$49.47	$60.31	$71.16
2021-10-08	$49.20	$60.04	$70.89
2021-10-11	$48.93	$59.77	$70.62
2021-10-12	$48.66	$59.51	$70.35
2021-10-13	$48.39	$59.24	$70.08
2021-10-14	$48.12	$58.97	$69.81
2021-10-15	$47.85	$58.70	$69.54
2021-10-18	$47.58	$58.43	$69.27
2021-10-19	$47.31	$58.16	$69.00
2021-10-20	$47.04	$57.89	$68.73
2021-10-21	$46.77	$57.62	$68.46
2021-10-22	$46.50	$57.35	$68.19
2021-10-25	$46.23	$57.08	$67.92
2021-10-26	$45.96	$56.81	$67.65
2021-10-27	$45.69	$56.54	$67.38
2021-10-28	$45.42	$56.27	$67.11
2021-10-29	$45.15	$56.00	$66.84
2021-11-01	$44.88	$55.73	$66.57
2021-11-02	$44.61	$55.46	$66.30

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops novel drugs to treat intractable diseases in the United States. The company utilizes its proprietary Dynamic Polyconjugate platform to develop targeted drugs based on the RNA interference mechanism that silences disease-causing genes. Its ARC-520, an RNAi-based therapeutic that is in Phase IIb clinical efficacy studies to treat chronic hepatitis B virus infection; and ARC-AAT,... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!